{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:47:18Z","timestamp":1792817238219,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["5M-2020-23682534"],"award-info":[{"award-number":["5M-2020-23682534"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA ES101081"],"award-info":[{"award-number":["ZIA ES101081"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["209\/2023"],"award-info":[{"award-number":["209\/2023"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ard.2025.04.024","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T07:27:10Z","timestamp":1747898830000},"page":"1055-1067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society\/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9658-0385","authenticated-orcid":false,"given":"Angelo","family":"Ravelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3667-6155","authenticated-orcid":false,"given":"Silvia","family":"Rosina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1543-0641","authenticated-orcid":false,"given":"Jayne M.","family":"MacMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3973-3442","authenticated-orcid":false,"given":"Ana Isabel","family":"Rebollo-Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9247-4729","authenticated-orcid":false,"given":"Claas","family":"Hinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0372-5758","authenticated-orcid":false,"given":"Liza J.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4521-7647","authenticated-orcid":false,"given":"Ann M.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-2458","authenticated-orcid":false,"given":"Lisa G.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Arvigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bader-Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3426-2901","authenticated-orcid":false,"given":"Claudio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Caifeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1894-8516","authenticated-orcid":false,"given":"Raquel","family":"Campanilho-Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cuccato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9027-343X","authenticated-orcid":false,"given":"Chiara","family":"Fiorillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki A.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-1689","authenticated-orcid":false,"given":"Adam M.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6969-8759","authenticated-orcid":false,"given":"Marc","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-7720","authenticated-orcid":false,"given":"Ozgur","family":"Kasapcopur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3898-7555","authenticated-orcid":false,"given":"Maria Martha","family":"Katsikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2159-8059","authenticated-orcid":false,"given":"Susan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0824-3878","authenticated-orcid":false,"given":"Polly","family":"Livermore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Malattia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1146-7963","authenticated-orcid":false,"given":"Angela Nyangore","family":"Migowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0568-1496","authenticated-orcid":false,"given":"Takako","family":"Miyamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4298-0628","authenticated-orcid":false,"given":"Rebecca","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1237-0557","authenticated-orcid":false,"given":"Charalampia","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Pilkington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7226-066X","authenticated-orcid":false,"given":"Helga","family":"Sanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Smolewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8583-7878","authenticated-orcid":false,"given":"Stacey E.","family":"Tarvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-8833","authenticated-orcid":false,"given":"Georgina","family":"Tiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-1646","authenticated-orcid":false,"given":"Natasa","family":"Toplak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7495-1429","authenticated-orcid":false,"given":"Lucy R.","family":"Wedderburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3823-4000","authenticated-orcid":false,"given":"Francesca","family":"Bovis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0065-7614","authenticated-orcid":false,"given":"Alessandro","family":"Consolaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7813-9665","authenticated-orcid":false,"given":"Brian M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9631","key":"10.1016\/j.ard.2025.04.024_bib0001","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood","volume":"371","author":"Feldman","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ard.2025.04.024_bib0002","series-title":"Textbook of pediatric rheumatology","first-page":"360","article-title":"Juvenile dermatomyositis and other inflammatory muscle diseases","author":"Pilkington","year":"2021"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0003","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.ard.2025.04.024_bib0004","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/art.24904","article-title":"Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index","volume":"60","author":"Rider","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ard.2025.04.024_bib0005","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/acr.21637","article-title":"Quality of life in adults with juvenile-onset dermatomyositis: a case-control study","volume":"64","author":"Tollisen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"10.1016\/j.ard.2025.04.024_bib0006","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/acr.20203","article-title":"Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: a case-control study","volume":"62","author":"Sanner","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"11","key":"10.1016\/j.ard.2025.04.024_bib0007","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/acr.20280","article-title":"The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis","volume":"62","author":"Ruperto","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.ard.2025.04.024_bib0008","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"10019","key":"10.1016\/j.ard.2025.04.024_bib0009","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","article-title":"Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial","volume":"387","author":"Ruperto","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ard.2025.04.024_bib0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","article-title":"Consensus-based recommendations for the management of juvenile dermatomyositis","volume":"76","author":"Bellutti Enders","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-016-0134-0","article-title":"Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease","volume":"15","author":"Kim","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0012","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3899\/jrheum.160688","article-title":"Childhood arthritis and rheumatology research alliance consensus clinical treatment plans for juvenile dermatomyositis with persistent skin rash","volume":"44","author":"Huber","year":"2017","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.ard.2025.04.024_bib0013","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/acr.20695","article-title":"Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference","volume":"64","author":"Huber","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.ard.2025.04.024_bib0014","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/acr.20071","article-title":"Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children\u2019s Arthritis and Rheumatology Research Alliance Consensus Conference","volume":"62","author":"Huber","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.ard.2025.04.024_bib0015","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/acr.25393","article-title":"Childhood arthritis and rheumatology research alliance biologic disease-modifying antirheumatic drug consensus treatment plans for refractory moderately severe juvenile dermatomyositis","volume":"76","author":"Tarvin","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.ard.2025.04.024_bib0016","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/annrheumdis-2017-212141","article-title":"Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research","volume":"77","author":"McCann","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.ard.2025.04.024_bib0017","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/rheumatology\/key421","article-title":"Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis","volume":"58","author":"Rosina","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003093","article-title":"Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity Index","volume":"10","author":"Rosina","year":"2024","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.ard.2025.04.024_bib0019","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","article-title":"The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis","volume":"72","author":"Lazarevic","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ard.2025.04.024_bib0020","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/art.39200","article-title":"Analysis of published criteria for clinically inactive disease in a large juvenile dermatomyositis cohort shows that skin disease is underestimated","volume":"67","author":"Almeida","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.ard.2025.04.024_bib0021","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/annrheumdis-2017-211401","volume":"76","author":"Rider","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"9430","key":"10.1016\/j.ard.2025.04.024_bib0022","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","article-title":"Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial","volume":"364","author":"Grigor","year":"2004","journal-title":"Lancet"},{"issue":"2 Suppl","key":"10.1016\/j.ard.2025.04.024_bib0023","first-page":"S126","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial","volume":"58","author":"Goekoop-Ruiterman","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0024","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","article-title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force","volume":"75","author":"Smolen","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 73","key":"10.1016\/j.ard.2025.04.024_bib0026","first-page":"S157","article-title":"Toward a treat-to-target approach in the management of juvenile idiopathic arthritis","volume":"30","author":"Consolaro","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.ard.2025.04.024_bib0027","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2014.212","article-title":"Management of juvenile idiopathic arthritis: hitting the target","volume":"11","author":"Hinze","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"10.1016\/j.ard.2025.04.024_bib0028","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11926-023-01112-x","article-title":"Treat-to-target in pediatric rheumatic diseases","volume":"25","author":"Rosina","year":"2023","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.ard.2025.04.024_bib0029","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/annrheumdis-2018-213030","article-title":"Treating juvenile idiopathic arthritis to target: recommendations of an international task force","volume":"77","author":"Ravelli","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ard.2025.04.024_bib0030","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/ard-2022-223328","article-title":"Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force","volume":"82","author":"Smith","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ard.2025.04.024_bib0031","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/ard.2004.023697","article-title":"EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees","volume":"63","author":"Dougados","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0032","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/annrheumdis-2014-206350","article-title":"2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations","volume":"74","author":"van der Heijde","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0033","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3899\/jrheum.191255","article-title":"Correlation of a modified disease activity score (DAS) with the validated original DAS in patients with juvenile dermatomyositis","volume":"48","author":"Clairman","year":"2021","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.ard.2025.04.024_bib0034","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/art.21291","article-title":"International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies","volume":"52","author":"Oddis","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ard.2025.04.024_bib0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.2042-7174.1996.tb00844.x","article-title":"The Delphi and nominal group techniques in health services research","volume":"4","author":"Cantrill","year":"2011","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.ard.2025.04.024_bib0036","series-title":"Sean Eby Poll Everywhere Software","author":"Jeff Vyduna","year":"2007"},{"key":"10.1016\/j.ard.2025.04.024_bib0037","series-title":"Oxford Centre for Evidence-Based Medicine: The Oxford 2011 Levels of Evidence","year":"2011"},{"issue":"12","key":"10.1016\/j.ard.2025.04.024_bib0038","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1136\/ard.2011.153718","article-title":"Efficacy of intravenous Ig therapy in juvenile dermatomyositis","volume":"70","author":"Lam","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ard.2025.04.024_bib0039","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s100670050032","article-title":"Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate","volume":"19","author":"Al-Mayouf","year":"2000","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.ard.2025.04.024_bib0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.122196","article-title":"Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis","volume":"47","author":"Fisler","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0041","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12969-022-00785-5","article-title":"Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance","volume":"21","author":"Sherman","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"10.1016\/j.ard.2025.04.024_bib0042","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/art.24571","article-title":"Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment","volume":"60","author":"Kim","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0043","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12969-018-0256-7","article-title":"Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists","volume":"16","author":"Hinze","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"10.1016\/j.ard.2025.04.024_bib0044","doi-asserted-by":"crossref","first-page":"433","DOI":"10.55563\/clinexprheumatol\/94btoy","article-title":"Myositis-specific autoantibodies and their associated phenotypes in juvenile dermatomyositis: data from a German cohort","volume":"40","author":"Horn","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.ard.2025.04.024_bib0045","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1093\/rheumatology\/keab108","article-title":"Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study","volume":"60","author":"Yamasaki","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ard.2025.04.024_bib0046","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","article-title":"Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort","volume":"84","author":"Tansley","year":"2017","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.ard.2025.04.024_bib0047","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/art.42768","article-title":"Clinical features and immunogenetic risk factors associated with additional autoantibodies in anti-transcriptional intermediary factor 1\u03b3 juvenile-onset dermatomyositis","volume":"76","author":"Sherman","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.ard.2025.04.024_bib0048","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.42813","article-title":"Myositis-associated autoantibodies in patients with juvenile myositis are associated with refractory disease and mortality","volume":"76","author":"Sherman","year":"2024","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.ard.2025.04.024_bib0049","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1002\/art.23960","article-title":"Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features","volume":"58","author":"Stringer","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.ard.2025.04.024_bib0050","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/art.27379","article-title":"Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis","volume":"62","author":"Ostrowski","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.ard.2025.04.024_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2024.101976","article-title":"Personalised medicine in juvenile dermatomyositis: from novel insights in disease mechanisms to changes in clinical practice","volume":"38","author":"Veldkamp","year":"2024","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.ard.2025.04.024_bib0052","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/acr.23338","article-title":"Assessment of microvascular abnormalities by nailfold capillaroscopy in juvenile dermatomyositis after medium- to long-term followup","volume":"70","author":"Barth","year":"2018","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0053","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12969-023-00903-x","article-title":"Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity","volume":"21","author":"Pachman","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0054","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12969-023-00919-3","article-title":"Juvenile dermatomyositis: association between nail fold capillary end row loop- area under the curve- and disease damage indicators","volume":"21","author":"Khojah","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"10.1016\/j.ard.2025.04.024_bib0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/art.23299","article-title":"Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis","volume":"58","author":"Christen-Zaech","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ard.2025.04.024_bib0056","first-page":"1250","article-title":"Early abnormal nailfold capillary changes are predictive of calcinosis development in juvenile dermatomyositis","volume":"49","author":"Nozawa","year":"2022","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.ard.2025.04.024_bib0057","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41390-023-02894-7","article-title":"Artificial intelligence for nailfold capillaroscopy analyses\u2014a proof of concept application in juvenile dermatomyositis","volume":"95","author":"Kassani","year":"2024","journal-title":"Pediatr Res"},{"issue":"6","key":"10.1016\/j.ard.2025.04.024_bib0058","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/annrheumdis-2012-202915","article-title":"Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis","volume":"73","author":"Malattia","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ard.2025.04.024_bib0059","first-page":"441","article-title":"Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies","volume":"55","author":"Yao","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.ard.2025.04.024_bib0060","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/rheumatology\/keh130","article-title":"Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis","volume":"43","author":"Maillard","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.ard.2025.04.024_bib0061","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/art.23012","article-title":"International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials","volume":"57","author":"Wedderburn","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0062","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/annrheumdis-2013-203396","article-title":"Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease","volume":"74","author":"Varsani","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ard.2025.04.024_bib0063","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.39753","article-title":"Muscle biopsy findings in combination with myositis-specific autoantibodies aid prediction of outcomes in juvenile dermatomyositis","volume":"68","author":"Deakin","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.ard.2025.04.024_bib0064","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/rheumatology\/keab601","article-title":"Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response","volume":"61","author":"Lerkvaleekul","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.ard.2025.04.024_bib0065","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/art.40881","article-title":"Galectin-9 and CXCL10 as biomarkers for disease activity in juvenile dermatomyositis: a longitudinal cohort study and multicohort validation","volume":"71","author":"Wienke","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.ard.2025.04.024_bib0066","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/03009742.2013.879674","article-title":"Quantitative muscle ultrasound: a potential tool for assessment of disease activity in juvenile dermatomyositis","volume":"43","author":"Bhansing","year":"2014","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.ard.2025.04.024_bib0067","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/mus.24564","article-title":"Quantitative muscle ultrasonography in the follow-up of juvenile dermatomyositis","volume":"52","author":"Habers","year":"2015","journal-title":"Muscle Nerve"},{"issue":"SI","key":"10.1016\/j.ard.2025.04.024_bib0068","doi-asserted-by":"crossref","first-page":"SI48","DOI":"10.1093\/rheumatology\/keab833","article-title":"Preliminary validation of muscle ultrasound in juvenile dermatomyositis (JDM)","volume":"61","author":"Mamyrova","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.ard.2025.04.024_bib0069","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3476(83)80706-9","article-title":"Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification","volume":"103","author":"Bowyer","year":"1983","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.ard.2025.04.024_bib0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1525-1470.1985.tb00465.x","article-title":"Prognosis in juvenile dermatopolymyositis: a cooperative retrospective study of 70 cases","volume":"2","author":"Taieb","year":"1985","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.ard.2025.04.024_bib0071","first-page":"621","article-title":"Long-term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy","volume":"17","author":"Huang","year":"1999","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0072","article-title":"Achieving medication-free remission in patients with juvenile dermatomyositis","volume":"7","author":"Maccora","year":"2025","journal-title":"ACR Open Rheumatol"},{"issue":"5","key":"10.1016\/j.ard.2025.04.024_bib0073","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1093\/rheumatology\/keaa371","article-title":"Corticosteroid discontinuation, complete clinical response and remission in juvenile dermatomyositis","volume":"60","author":"Kishi","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.ard.2025.04.024_bib0074","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nrrheum.2018.33","article-title":"Update on outcome assessment in myositis","volume":"14","author":"Rider","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"0 11","key":"10.1016\/j.ard.2025.04.024_bib0075","first-page":"S118","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.ard.2025.04.024_bib0076","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/art.23248","volume":"59","author":"Ruperto","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ard.2025.04.024_bib0077","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/art.21378","article-title":"The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids","volume":"52","author":"Ramanan","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ard.2025.04.024_bib0078","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/art.23829","article-title":"The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis","volume":"59","author":"Seshadri","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.ard.2025.04.024_bib0079","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/rheumatology\/kep302","article-title":"Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset","volume":"48","author":"Sanner","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ard.2025.04.024_bib0080","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/art.24343","article-title":"Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study","volume":"61","author":"Apaz","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.ard.2025.04.024_bib0081","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-156-5-201203060-00004","article-title":"Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial","volume":"156","author":"Bakker","year":"2012","journal-title":"Ann Intern Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725009501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725009501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:07:09Z","timestamp":1778040429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725009501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":81,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0003496725009501"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.04.024","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society\/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Alliance of Associations for Rheumatology (EULAR). Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}